🇺🇸 FDA
Patent

US 10874334

Methods and systems for quantification of blood-brain barrier permeation of glycosylated peptides

granted A61KA61K38/08

Quick answer

US patent 10874334 (Methods and systems for quantification of blood-brain barrier permeation of glycosylated peptides) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/08